Beamish H[au] - Search Results

Year	Number of Results
1994	4
1995	2
1996	3
1997	2
1998	2
1999	2
2000	1
2002	1
2003	1
2004	4
2005	1
2006	1
2007	2
2008	3
2009	2
2010	1
2012	1
2013	1
2014	1
2022	0

1

Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase.

Lavin MF, Khanna KK, Beamish H, Spring K, Watters D, Shiloh Y. Lavin MF, et al. Among authors: beamish h. Trends Biochem Sci. 1995 Oct;20(10):382-3. doi: 10.1016/s0968-0004(00)89083-0. Trends Biochem Sci. 1995. PMID: 8533147 Review. No abstract available.

2

Histone deacetylase inhibitors induce mitotic slippage.

Stevens FE, Beamish H, Warrener R, Gabrielli B. Stevens FE, et al. Among authors: beamish h. Oncogene. 2008 Feb 28;27(10):1345-54. doi: 10.1038/sj.onc.1210779. Epub 2007 Sep 10. Oncogene. 2008. PMID: 17828304

3

Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells.

Gabrielli B, Chau YQ, Giles N, Harding A, Stevens F, Beamish H. Gabrielli B, et al. Among authors: beamish h. J Biol Chem. 2007 Mar 9;282(10):6954-64. doi: 10.1074/jbc.M610104200. Epub 2006 Dec 20. J Biol Chem. 2007. PMID: 17182611 Free article.

4

Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events.

De Boer L, Oakes V, Beamish H, Giles N, Stevens F, Somodevilla-Torres M, Desouza C, Gabrielli B. De Boer L, et al. Among authors: beamish h. Oncogene. 2008 Jul 17;27(31):4261-8. doi: 10.1038/onc.2008.74. Epub 2008 Mar 31. Oncogene. 2008. PMID: 18372919

5

Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.

Oakes V, Wang W, Harrington B, Lee WJ, Beamish H, Chia KM, Pinder A, Goto H, Inagaki M, Pavey S, Gabrielli B. Oakes V, et al. Among authors: beamish h. Cell Cycle. 2014;13(20):3302-11. doi: 10.4161/15384101.2014.949111. Cell Cycle. 2014. PMID: 25485510 Free PMC article.

6

Cyclin A/cdk2 regulates adenomatous polyposis coli-dependent mitotic spindle anchoring.

Beamish H, de Boer L, Giles N, Stevens F, Oakes V, Gabrielli B. Beamish H, et al. J Biol Chem. 2009 Oct 16;284(42):29015-23. doi: 10.1074/jbc.M109.042820. Epub 2009 Aug 24. J Biol Chem. 2009. PMID: 19703905 Free PMC article.

7

Analysis of checkpoint responses to histone deacetylase inhibitors.

Beamish H, Warrener R, Gabrielli BG. Beamish H, et al. Methods Mol Biol. 2004;281:245-59. doi: 10.1385/1-59259-811-0:245. Methods Mol Biol. 2004. PMID: 15220534

8

A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress.

Brooks K, Oakes V, Edwards B, Ranall M, Leo P, Pavey S, Pinder A, Beamish H, Mukhopadhyay P, Lambie D, Gabrielli B. Brooks K, et al. Among authors: beamish h. Oncogene. 2013 Feb 7;32(6):788-96. doi: 10.1038/onc.2012.72. Epub 2012 Mar 5. Oncogene. 2013. PMID: 22391562

9

Defining the chemotherapeutic targets of histone deacetylase inhibitors.

Gabrielli B, Warrener R, Burgess A, Beamish H. Gabrielli B, et al. Among authors: beamish h. Ann N Y Acad Sci. 2004 Dec;1030:627-35. doi: 10.1196/annals.1329.073. Ann N Y Acad Sci. 2004. PMID: 15659846

10

The histone deacetylase inhibitor MGCD0103 has both deacetylase and microtubule inhibitory activity.

Chia K, Beamish H, Jafferi K, Gabrielli B. Chia K, et al. Among authors: beamish h. Mol Pharmacol. 2010 Sep;78(3):436-43. doi: 10.1124/mol.110.065169. Epub 2010 Jun 10. Mol Pharmacol. 2010. PMID: 20538840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results